A Three-Hybrid Approach to Scanning the Proteome for Targets of Small Molecule Kinase Inhibitors-Reference-Cited by-同舟云学术

A Three-Hybrid Approach to Scanning the Proteome for Targets of Small Molecule Kinase Inhibitors

Published:2004-02 Issue:2 Volume:11 Page:211-223
ISSN:1074-5521
Container-title:Chemistry & Biology
language:en
Short-container-title:Chemistry & Biology

Author:

Becker Frank,Murthi Krishna,Smith Chase,Come Jon,Costa-Roldán Nuria,Kaufmann Christine,Hanke Urs,Degenhart Carsten,Baumann Sabine,Wallner Wolfgang,Huber Andrea,Dedier Severine,Dill Simone,Kinsman David,Hediger Mark,Bockovich Nicholas,Meier-Ewert Sebastian,Kluge Arthur F,Kley Nikolai

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,General Medicine,Biochemistry

Reference42 articles.

1. A three-hybrid system for detecting small ligand-protein receptor interactions;Licitra;Proc. Natl. Acad. Sci. USA,1996

2. Isolation of cDNAs encoding cellular drug-binding proteins using a novel expression cloning procedure;Tanaka;Mol. Pharmacol.,1999

3. Display cloning;Sche;Chem. Biol.,1999

4. Drug receptor identification from multiple tissues using cellular-derived mRNA display libraries;McPherson;Chem. Biol.,2002

5. A novel genetic system to detect protein-protein interactions;Fields;Nature,1989

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trawling the Genome: Drug Target Identification in the Postgenomic Era;Drugs from Nature: Targets, Assay Systems and Leads;2024

2. A Normalization Protocol Reduces Edge Effect in High-Throughput Analyses of Hydroxyurea Hypersensitivity in Fission Yeast;Biomedicines;2023-10-18

3. Using the yeast three-hybrid system for the identification of small molecule-protein interactions with the example of ethinylestradiol;Biological Chemistry;2022-02-28

4. Impact of Metabolic Regulation in Understanding the Status of Human Health and Diseases: A Review;International Journal of Life Science and Pharma Research;2022-01-31

5. General Strategies for Rational Design and Discovery of Multitarget Drugs;Polypharmacology;2022